Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine Against Chronic Rheumatoid Arthritis Fatigue
2022-500922-13-00Phase 3Completed
- Sponsor
- Aarhus University Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing High-dose thiamine with Placebo (2 arms). Primary endpoint: Change in fatigue level at 4 weeks. Started Oct 2022; status: completed.
02
Drugs
thiamine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2022-500922-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500922-13-00.